[go: up one dir, main page]

PL3150227T3 - Nieorganiczne nanocząstki o dużej gęstości do niszczenia komórek in vivo - Google Patents

Nieorganiczne nanocząstki o dużej gęstości do niszczenia komórek in vivo

Info

Publication number
PL3150227T3
PL3150227T3 PL16187263T PL16187263T PL3150227T3 PL 3150227 T3 PL3150227 T3 PL 3150227T3 PL 16187263 T PL16187263 T PL 16187263T PL 16187263 T PL16187263 T PL 16187263T PL 3150227 T3 PL3150227 T3 PL 3150227T3
Authority
PL
Poland
Prior art keywords
vivo
high density
inorganic nanoparticles
destroy cells
destroy
Prior art date
Application number
PL16187263T
Other languages
English (en)
Inventor
Laurent Levy
Agnès Pottier
Annabelle Rouet
Julie Marill
Corinne Devaux
Matthieu Germain
Original Assignee
Nanobiotix
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanobiotix filed Critical Nanobiotix
Publication of PL3150227T3 publication Critical patent/PL3150227T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/244—Lanthanides; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Radiation-Therapy Devices (AREA)
  • Medicinal Preparation (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL16187263T 2008-06-05 2009-06-04 Nieorganiczne nanocząstki o dużej gęstości do niszczenia komórek in vivo PL3150227T3 (pl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP08157686A EP2130553A1 (en) 2008-06-05 2008-06-05 Inorganic nanoparticles of high density to destroy cells in-vivo
US6020208P 2008-06-10 2008-06-10
EP09757595.5A EP2300054B1 (en) 2008-06-05 2009-06-04 Inorganic nanoparticles of high density to destroy cells in-vivo
PCT/EP2009/056880 WO2009147214A2 (en) 2008-06-05 2009-06-04 Inorganic nanoparticles, preparation and uses thereof
EP16187263.5A EP3150227B1 (en) 2008-06-05 2009-06-04 Inorganic nanoparticles of high density to destroy cells in-vivo

Publications (1)

Publication Number Publication Date
PL3150227T3 true PL3150227T3 (pl) 2019-05-31

Family

ID=39734334

Family Applications (2)

Application Number Title Priority Date Filing Date
PL09757595T PL2300054T3 (pl) 2008-06-05 2009-06-04 Nieorganiczne nanocząstki o dużej gęstości do niszczenia komórek in vivo
PL16187263T PL3150227T3 (pl) 2008-06-05 2009-06-04 Nieorganiczne nanocząstki o dużej gęstości do niszczenia komórek in vivo

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL09757595T PL2300054T3 (pl) 2008-06-05 2009-06-04 Nieorganiczne nanocząstki o dużej gęstości do niszczenia komórek in vivo

Country Status (26)

Country Link
US (1) US8845507B2 (pl)
EP (4) EP2130553A1 (pl)
JP (1) JP5734181B2 (pl)
KR (1) KR101639281B1 (pl)
CN (1) CN102056628B (pl)
AU (1) AU2009254550B2 (pl)
BR (1) BRPI0913410B1 (pl)
CA (1) CA2727576C (pl)
CY (2) CY1118217T1 (pl)
DK (2) DK2300054T3 (pl)
EA (1) EA023012B1 (pl)
ES (2) ES2702249T3 (pl)
HR (2) HRP20161465T8 (pl)
HU (2) HUE030669T2 (pl)
IL (1) IL209625A (pl)
LT (2) LT3150227T (pl)
MA (1) MA32453B1 (pl)
MX (1) MX2010013322A (pl)
NZ (1) NZ589888A (pl)
PL (2) PL2300054T3 (pl)
PT (2) PT2300054T (pl)
SG (1) SG10201405288WA (pl)
SI (2) SI2300054T1 (pl)
TR (1) TR201819077T4 (pl)
WO (1) WO2009147214A2 (pl)
ZA (1) ZA201100082B (pl)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070164238A1 (en) * 2003-02-24 2007-07-19 Pomper Mark E Mobile radiation treatment vehicle and method
US8657354B2 (en) 2006-05-19 2014-02-25 Breya, Llc. Mobile radiation therapy
US8459714B2 (en) 2006-05-19 2013-06-11 Breya, Llc. Mobile radiation therapy
US9399075B2 (en) 2008-12-29 2016-07-26 General Electric Company Nanoparticle contrast agents for diagnostic imaging
US8728440B2 (en) 2012-08-23 2014-05-20 General Electric Company Nanoparticulate compositions for diagnostic imaging
EP2275137A1 (en) 2009-07-10 2011-01-19 Nanobiotix Metallic nanoparticles, preparation and uses thereof
US9585840B1 (en) 2009-07-10 2017-03-07 University Of Central Florida Research Foundation, Inc. Redox active cerium oxide nanoparticles and associated methods
CN107149689A (zh) 2009-11-10 2017-09-12 免疫之光有限责任公司 对可辐射固化介质进行固化的系统和产生光的方法
WO2012058271A2 (en) 2010-10-27 2012-05-03 Pixelligent Technologies, Llc Synthesis, capping and dispersion of nanocrystals
WO2011133228A2 (en) * 2010-04-23 2011-10-27 Pixelligent Technologies, Llc Synthesis, capping and dispersion of nanocrystals
US9359689B2 (en) 2011-10-26 2016-06-07 Pixelligent Technologies, Llc Synthesis, capping and dispersion of nanocrystals
CN104093401B (zh) 2011-12-16 2018-06-29 纳米生物技术公司 包含金属材料和氧化铪材料的纳米粒子、其制备和用途
CA2874761A1 (en) * 2012-06-14 2013-12-19 Board Of Trustees Of The University Of Arkansas Compositions and methods for non-invasive detection and treatment of hypoxic cells in vivo
US8821838B2 (en) 2012-08-23 2014-09-02 General Electric Company Nanoparticulate compositions for diagnostic imaging
MX369664B (es) * 2013-01-25 2019-11-14 Nanobiotix Composiciones de nanoparticulas inorganicas en combinacion con radiaciones ionizantes para tratar el cancer.
AU2014219129B2 (en) * 2013-02-19 2016-07-28 National Health Research Institutes Caged platinum nanoclusters for anticancer chemotherapeutics
CN105407878A (zh) 2013-05-30 2016-03-16 纳米生物技术公司 药物组合物、制备及其用途
CN105431141A (zh) * 2013-06-20 2016-03-23 纳米生物技术公司 用于医学诊断的组合物及方法
MX371092B (es) * 2013-12-16 2020-01-16 Genentech Inc Compuestos peptidomimeticos y conjugados de anticuerpo-farmaco de los mismos.
EP2886128A1 (en) 2013-12-20 2015-06-24 Nanobiotix Pharmaceutical composition comprising nanoparticles, preparation and uses thereof
JP6836510B2 (ja) 2014-11-25 2021-03-03 キュラディグム・エスアエスＣｕｒａｄｉｇｍ Ｓａｓ 少なくとも２つの異なるナノ粒子と医薬化合物とを組み合わせた医薬組成物、その調製及び使用
MX2017006813A (es) 2014-11-25 2018-01-30 Nanobiotix Composicion farmaceutica, preparacion y usos de la misma.
TW201628610A (zh) 2014-11-25 2016-08-16 奈諾生技公司 醫藥組合物、其製備及其用途
DK3229843T3 (da) 2014-11-25 2020-03-09 Curadigm Sas Farmaceutisk sammensætning, præparat og anvendelser deraf
US10765632B2 (en) 2014-11-25 2020-09-08 Curadigm Sas Methods of improving delivery of compounds for therapy, prophylaxis or diagnosis
WO2016112314A1 (en) * 2015-01-08 2016-07-14 Purdue Research Foundation Non-toxic formulations of radio-luminescent nanoparticles for use as cancer radio-sensitizing agents
EA201792560A1 (ru) * 2015-05-28 2018-06-29 Нанобиотикс Наночастицы для применения в качестве терапевтической вакцины
US11389536B2 (en) 2015-07-17 2022-07-19 BioCurity Pharmaceuticals Inc. Treatment of cancer with a combination of radiation, cerium oxide nanoparticles, and a chemotherapeutic agent
CN109010828B (zh) * 2018-10-12 2020-10-20 中国科学院高能物理研究所 一种二硫化钼/二氧化铪的复合纳米材料、其制备方法及用途
CN109616308B (zh) * 2018-11-07 2020-09-04 湖北第二师范学院 一种球形纳米氧化铱dna提取磁性粉末及其生产方法
CN109771645B (zh) * 2019-03-07 2021-08-24 广西师范大学 一种二氧化钌复合卵清蛋白纳米材料的制备及其应用
KR20230038659A (ko) * 2020-05-26 2023-03-21 나노비오띡스 나노 입자, 전리 방사선 및 그의 혁신적인 치료용 조합
JP2023549698A (ja) * 2020-11-05 2023-11-29 ナノビオティックス がんの治療のためのナノ粒子の組成物
CA3199321A1 (en) * 2020-12-01 2022-06-09 Laurent Levy Porous, high-z and carbon-free particles as radioenhancers
EP4633676A1 (en) 2022-12-12 2025-10-22 Nanobiotix Novel metal oxide nanoparticles and compositions thereof for use as radioenhancers or for visualizing biological tissue
EP4595983A1 (en) 2024-02-05 2025-08-06 BXTA Nanotherapy Limited Nanoparticles functionalised with a stabilising agent and a targeting agent

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6287526A (ja) * 1985-10-11 1987-04-22 Akira Fujishima 抗腫瘍剤
US6645464B1 (en) 1998-07-30 2003-11-11 James F. Hainfeld Loading metal particles into cell membrane vesicles and metal particular use for imaging and therapy
WO2005058360A2 (en) 2003-12-17 2005-06-30 Philips Intellectual Property & Standards Gmbh Radiation therapy and medical imaging using uv emitting nanoparticles
FR2869803B1 (fr) * 2004-05-10 2006-07-28 Nanobiotix Sarl Particules activables, preparation et utilisations
US20070092927A1 (en) * 2005-06-13 2007-04-26 University Of Dayton Photocatalytic particles with directed and controlled redox activity
JP2007075696A (ja) * 2005-09-13 2007-03-29 Mitsubishi Materials Corp 多孔質光触媒膜
WO2008007290A2 (en) * 2006-07-10 2008-01-17 Philips Intellectual Property & Standards Gmbh Core-shell nanoparticles for thearapy and imaging purposes
EP1920784A1 (en) * 2006-11-13 2008-05-14 Koninklijke Philips Electronics N.V. Radiation sensitizers in ionizing radiation therapy and imaging

Also Published As

Publication number Publication date
BRPI0913410A2 (pt) 2015-11-24
TR201819077T4 (tr) 2019-01-21
BRPI0913410B1 (pt) 2021-09-21
AU2009254550A1 (en) 2009-12-10
SI3150227T1 (sl) 2019-02-28
HUE040247T2 (hu) 2019-02-28
CA2727576C (en) 2016-08-16
HRP20161465T8 (hr) 2017-04-21
JP2011524866A (ja) 2011-09-08
DK2300054T3 (en) 2016-12-05
EA023012B1 (ru) 2016-04-29
CY1118217T1 (el) 2017-06-28
KR101639281B1 (ko) 2016-07-13
US20110213192A1 (en) 2011-09-01
EP2300054B1 (en) 2016-09-07
KR20110028616A (ko) 2011-03-21
EP3150227A1 (en) 2017-04-05
EP3461502A1 (en) 2019-04-03
HRP20181993T1 (hr) 2019-01-25
JP5734181B2 (ja) 2015-06-17
WO2009147214A3 (en) 2010-02-25
US8845507B2 (en) 2014-09-30
EP2130553A1 (en) 2009-12-09
EP3150227B1 (en) 2018-10-31
PL2300054T3 (pl) 2017-04-28
WO2009147214A2 (en) 2009-12-10
EA201071429A1 (ru) 2011-06-30
CA2727576A1 (en) 2009-12-10
DK3150227T3 (en) 2019-01-14
IL209625A0 (en) 2011-02-28
SI2300054T1 (sl) 2017-02-28
ZA201100082B (en) 2011-10-26
SG10201405288WA (en) 2014-10-30
LT3150227T (lt) 2018-12-10
PT2300054T (pt) 2016-11-11
CY1121078T1 (el) 2019-12-11
MX2010013322A (es) 2011-01-21
AU2009254550B2 (en) 2013-10-24
CN102056628A (zh) 2011-05-11
NZ589888A (en) 2012-06-29
IL209625A (en) 2015-11-30
EP2300054A2 (en) 2011-03-30
HRP20161465T1 (hr) 2017-01-27
ES2702249T3 (es) 2019-02-28
PT3150227T (pt) 2018-12-24
CN102056628B (zh) 2013-07-10
MA32453B1 (fr) 2011-07-03
HUE030669T2 (en) 2017-05-29
ES2602048T3 (es) 2017-02-17
LT2300054T (lt) 2016-12-27

Similar Documents

Publication Publication Date Title
HRP20181993T1 (hr) Anorganske nanočestice visoke gustoće za uništavanje stanica in-vivo
ZA201008392B (en) Treatment of pluripotent cells
GB2480042B (en) Solid oral unit-dosage prebiotic forms and methods of use
SG10201401643PA (en) Methods for assessing cytotoxicity of single cells
IL213582A0 (en) Generation and maintenance of stem cells
EP2391579A4 (en) NANOPARTICLE COMPOSITIONS WITH MODIFIED SURFACE
ZA201109227B (en) Incorporation of nanoparticles in composite fibers
IL218964A0 (en) Phototriggered nanoparticles for cell and tissue targeting
GB0803378D0 (en) Reactor for the manufacture of nanoparticles
EP2393930A4 (en) CELLULAR LINES EXPRESSING CFTR AND METHODS OF USE THEREOF
GB0808965D0 (en) Equipment to stimulate photosensitized cells
GB0911042D0 (en) Treatment of tumorigenic cells in solid tumours
IL211567A0 (en) Use of stem cells to prevent neuronal dieback
IL216842A (en) Methods for producing hybrid / chimeric cells and their uses
GB0912103D0 (en) Energy consumption monitor
TWM344943U (en) Retention structure of socket
GB0915732D0 (en) Improvements in or relating to exfoliation
GB0800165D0 (en) Combined hydrogen and power production
GB0922052D0 (en) Nanoparticle clusters formed from individual nanoparticles of two or more types
GB201015579D0 (en) Provision of electrical energy
EP2318570A4 (en) ELECTROLYTIC CELL AND RELATED METHODS FOR THE PRODUCTION AND USE THEREOF
TWM370966U (en) Structure of travel backpack
TWM371297U (en) Improved structure of power lock
TWM374201U (en) Improved structure of power connector
GB0820741D0 (en) Treatise on aspects of matter and energy